SBI² 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Novartis at SBI² 2026

Nov 2–4, 2026 Boston, MA ~300 attendees Website

Novartis takes part in 1 session at SBI² 2026 in Boston. Its program looks at how drug discovery has changed over the past three decades, and how recent AI methods apply to its long-standing problems.

OrganizationSBI² 2026 Attendance
Novartis
Basel, Switzerland
Large pharma
Swiss pharmaceutical company developing medicines for cardiovascular, cancer, immune and neurological diseases.
Keynote
Tue Nov 3
4:30pm–5:30pm
Drug Discovery: How We Got Here and Where We Might Be Going
How drug discovery has changed over the past three decades, and how recent AI methods apply to its long-standing problems.
Image analysis, data and AI

Explore the full SBI² 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full SBI² 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Novartis

Tell us what you sell and we’ll find the people at Novartis most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society of Biomolecular Imaging and Informatics. Submit a correction